Citation Impact
Citing Papers
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Breast cancer
2019 Standout
Breast cancer stem cells: implications for therapy of breast cancer
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients
2006
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Triple-Negative Breast Cancer
2010 Standout
Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment
2008
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Breast cancer
2016 Standout
Cancer to bone: a fatal attraction
2011 Standout
Chemotaxis in cancer
2011
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
2012
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer
2003
Tumour heterogeneity in the clinic
2013 Nature
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Immunology and immunotherapy of colorectal cancer
2003
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
2006
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
2007
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Circulating tumour cells in cancer patients: challenges and perspectives
2010
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Fear of cancer recurrence: specific profiles and nature of intrusive thoughts
2010
Molecular Determinants of Occult Metastatic Tumor Cells in Bone Marrow
2001
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
2010
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
2011
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
2013 Standout
Current and emerging concepts in tumour metastasis
2010
Enumeration of Circulating Tumor Cells in the Blood of Breast Cancer Patients After Filtration Enrichment: Correlation with Disease Stage
2004
Measuring Quality of Life in Cosmetic and Reconstructive Breast Surgery: A Systematic Review of Patient-Reported Outcomes Instruments
2007
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Development of a New Patient-Reported Outcome Measure for Breast Surgery: The BREAST-Q
2009 Standout
Dormancy in breast cancer
2012
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature
2011
Molecular mechanisms of metastasis in breast cancer—clinical applications
2010
Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance
2004
Frequent EpCam protein expression in human carcinomas
2004
Long-term patient survival in ANCA-associated vasculitis
2010 Standout
Breast cancer metastasis: markers and models
2005 Standout
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Docetaxel for the adjuvant treatment of early nodepositive breast cancer: a single technology appraisal
2009
Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network
2015
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Simultaneous Immunohistochemical Detection of Tumor Cells in Lymph Nodes and Bone Marrow Aspirates in Breast Cancer and Its Correlation With Other Prognostic Factors
2001
Effect of Endocrine Therapies on Bone in Breast Cancer Patients
2010
Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance
2002
Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.
2010
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Alemtuzumab for patients with chronic lymphocytic leukaemia
2012
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Comparative Analysis of Micrometastasis to the Bone Marrow and Lymph Nodes of Node-Negative Breast Cancer Patients Receiving No Adjuvant Therapy
2001
Impact of Breast Surgery in Primary Metastasized Breast Cancer
2018
Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
2003
Circulating tumor cells in solid tumor in metastatic and localized stages.
2009
Works of W Janni being referenced
Zoledronsäure bei persistierenden isolierten Tumorzellen im Knochenmark bei Mammakarzinom
2008
Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets
2016
Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
1999
Effect of zoledronate on persisting isolated tumor cells (ITC) in the bone marrow (BM) of patients without recurrence of early breast cancer
2004
Quality of life influenced by primary surgical treatment for stage I–III breast cancer - long-term follow-up of a matched-pair analysis
2001
Gesundheitsbezogene Lebensqualität, Körpererleben und Angst bei Brustkrebspatientinnen im Langzeitverlauf
2003
Association of persistence of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients with risk for relapse
2004
191 DETECT III – a Multicenter, Randomized, Phase III Study to Compare Standard Therapy Alone Versus Standard Therapy Plus Lapatinib in Patients with Initially HER2-negative Metastatic Breast Cancer and HER2-positive Circulating Tumor Cells
2012
Use of circulating tumor cells (CTC) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk for relapse: The SUCCESS trial.
2010
Contralateral breast cancer risk in patients with familial breast cancer who tested negative for BRCA1 and BRCA2.
2011
Influence of zoledronic acid on disseminated tumor cells (DTC) in primary breast cancer patients.
2009
Phase III study evaluating the role of docetaxel in the adjuvant setting of breast cancer patients with ≥ 4 involved lymph nodes: ADEBAR-Study
2005